Translational approaches to addressing complex genetic pathways in colorectal cancer

被引:14
作者
Early, Dayna S. [1 ,2 ,3 ]
Fontana, Luigi [1 ,2 ,3 ]
Davidson, Nicholas O. [1 ,2 ,3 ]
机构
[1] Washington Univ, Sch Med, Dept Internal Med, Div Gastroenterol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Ctr Human Nutr, Div Gastroenterol, St Louis, MO 63110 USA
[3] Ist Super Sanita, Div Food Sci Himan Nutr & Hlth, I-00161 Rome, Italy
关键词
D O I
10.1016/j.trsl.2007.09.002
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 [基础医学];
摘要
Colorectal cancer (CRC) is among the most prevalent cancers worldwide and represents a major public health challenge in the developed world. From the perspective of translational investigation, scientists have enormous opportunity to elucidate the molecular genetic mechanisms that contribute to CRC pathogenesis because most cancers develop from adenomatous precursor lesions. The process of adenoma growth and transformation is accompanied by cumulative mutations in dominant genetic pathways that confer a growth advantage. Although this developmental process permits interrogation of informative pathways before the development of cancer, only a few adenomas progress to CRC. Accordingly, a major challenge for clinical translational investigators is to identity the molecular signatures that indicate increased likelihood for adenoma progression. By corollary, these molecular signatures include mutations in high penetrance alleles, which include the Adenomatous Polyposis Coli (APC) gene as well as other alleles in the Wnt/beta-catenin signaling pathway that specify increased genetic susceptibility to CRC. Interactions between these high penetrance alleles and other modifier genes as well as with environmental factors are of particular importance to understand the complex network of events that lead to CRC. This brief review will highlight 3 areas where important questions concerning genetic and environmental risk factors have fueled translational investigation into possible pathways that lead to CRC. (Translational Research 2008;151:10-16).
引用
收藏
页码:10 / 16
页数:7
相关论文
共 63 条
[1]
Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial [J].
Anderson, GL ;
Limacher, M ;
Assaf, AR ;
Bassford, T ;
Beresford, SAA ;
Black, H ;
Bonds, D ;
Brunner, R ;
Brzyski, R ;
Caan, B ;
Chlebowski, R ;
Curb, D ;
Gass, M ;
Hays, J ;
Heiss, G ;
Hendrix, S ;
Howard, BV ;
Hsia, J ;
Hubbell, A ;
Jackson, R ;
Johnson, KC ;
Judd, H ;
Kotchen, JM ;
Kuller, L ;
LaCroix, AZ ;
Lane, D ;
Langer, RD ;
Lasser, N ;
Lewis, CE ;
Manson, J ;
Margolis, K ;
Ockene, J ;
O'Sullivan, MJ ;
Phillips, L ;
Prentice, RL ;
Ritenbaugh, C ;
Robbins, J ;
Rossouw, JE ;
Sarto, G ;
Stefanick, ML ;
Van Horn, L ;
Wactawski-Wende, J ;
Wallace, R ;
Wassertheil-Smoller, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (14) :1701-1712
[2]
Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, Rho-, and Rac-dependent signaling pathways [J].
Attoub, S ;
Noe, V ;
Pirola, L ;
Bruyneel, E ;
Chastre, E ;
Mareel, M ;
Wymann, MP ;
Gespach, C .
FASEB JOURNAL, 2000, 14 (14) :2329-2338
[3]
Body size and the risk of colon cancer in a large case-control study [J].
Caan, BJ ;
Coates, AO ;
Slattery, ML ;
Potter, JD ;
Quesenberry, CP ;
Edwards, SM .
INTERNATIONAL JOURNAL OF OBESITY, 1998, 22 (02) :178-184
[4]
Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms [J].
Calle, EE ;
Kaaks, R .
NATURE REVIEWS CANCER, 2004, 4 (08) :579-591
[5]
Senescent cells, tumor suppression, and organismal aging: Good citizens, bad neighbors [J].
Campisi, J .
CELL, 2005, 120 (04) :513-522
[6]
2-Methoxyestradiol induces p53-associated apoptosis of colorectal cancer cells [J].
Carothers, AM ;
Hughes, SA ;
Ortega, D ;
Bertagnolli, MM .
CANCER LETTERS, 2002, 187 (1-2) :77-86
[7]
Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-β-catenin signaling axis [J].
Castellone, MD ;
Teramoto, H ;
Williams, BO ;
Druey, KM ;
Gutkind, JS .
SCIENCE, 2005, 310 (5753) :1504-1510
[8]
Aspirin and the risk of colorectal cancer in relation to the expression of COX-2 [J].
Chan, Andrew T. ;
Ogino, Shuji ;
Fuchs, Charles S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (21) :2131-2142
[9]
Estrogen plus progestin and colorectal cancer in postmenopausal women [J].
Chlebowski, RT ;
Wactawski-Wende, J ;
Ritenbaugh, C ;
Hubbell, FA ;
Ascensao, J ;
Rodabough, RJ ;
Rosenberg, CA ;
Taylor, VM ;
Harris, R ;
Chen, C ;
Adams-Campbell, LL ;
White, E ;
Alving, B ;
Rossouw, J ;
Pottern, L ;
Ludlam, S ;
McGowan, J ;
Prentice, R ;
Anderson, G ;
LaCroix, A ;
Patterson, R ;
McTiernan, A ;
Cochrane, B ;
Hunt, J ;
Tinker, L ;
Kooperberg, C ;
McIntosh, M ;
Wang, CY ;
Chen, C ;
Bowen, D ;
Kristal, A ;
Stanford, J ;
Urban, N ;
Weiss, N ;
White, E ;
Shumaker, S ;
Rautaharju, P ;
Prineas, R ;
Naughton, M ;
Stein, E ;
Laskarzewski, P ;
Cummings, S ;
Nevitt, M ;
Dockrell, M ;
Harnack, L ;
Cammarata, F ;
Lindenfelser, S ;
Psaty, B ;
Heckbert, S ;
Wassertheil-Smoller, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (10) :991-1004
[10]
Inflammation and cancer [J].
Coussens, LM ;
Werb, Z .
NATURE, 2002, 420 (6917) :860-867